Evidence map›Paper›PMID 30693278›Full record

ArticleFrontiers in chemistry2018

Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety.

Shanshan Li, Jiajia Wang, Lanlan Zang, Hailiang Zhu, Jianshuang Guo, Jiabin Zhang, Liuqing Wen, Yi Chen, Yanhong Li, Xi Chen and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Advances in the biosynthesis of D-allulose.World journal of microbiology & biotechnology · 2024
    Review
  3. Article
  4. Article
  5. The Metabolic Chemical Reporter AcFrontiers in chemistry · 2021
    Article
  6. Machine-Driven Chemoenzymatic Synthesis of Glycopeptide.Angewandte Chemie (International ed. in English) · 2020
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Shanshan LiDepartment of Chemistry and Center of Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, United States.
Jiajia WangSchool of Basic Medical Sciences, Henan University Joint National Laboratory for Antibody Drug Engineering, Kaifeng, China.
Lanlan ZangCentral Laboratory, Linyi People's Hospital, Shandong University, Linyi, China.
Hailiang ZhuDepartment of Chemistry and Center of Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, United States.
Jianshuang GuoState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
Jiabin ZhangDepartment of Chemistry and Center of Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, United States.
Liuqing WenDepartment of Chemistry and Center of Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, United States.
Yi ChenDepartment of Chemistry, University of California, Davis, Davis, CA, United States.
Yanhong LiDepartment of Chemistry, University of California, Davis, Davis, CA, United States.
Xi ChenDepartment of Chemistry, University of California, Davis, Davis, CA, United States.
Peng George WangDepartment of Chemistry and Center of Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, United States.
Jing LiState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
Georgia State University · USUniversity of California, Davis · USState Key Laboratory of Medicinal Chemical BiologyHenan University · CNLinyi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlcNAc derivativesO-GlcNAcaseO-GlcNAcylationsubstrate specificitysugar moiety

Identifiers

PMID30693278
PMCPMC6340312
OpenAlexW2905243037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.